A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

NCT07268339 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

328

Enrollment

OTHER

Sponsor class

Conditions

High-Risk Non-Muscle Invasive Bladder Cancer

Interventions

RADIATION: radiotherapy
OTHER: BCG

Sponsor

The Christie NHS Foundation Trust